CorMura

Catheter ablation is the cornerstone treatment for atrial fibrillation, but the lesions it creates often don't hold. Tissue that was treated reconnects, the arrhythmia returns, and patients face a choice between another procedure and living with the condition, a choice many resolve by doing nothing. CorMura is developing an ablation platform built for durability from the ground up, founded by seasoned engineering entrepreneurs and developed alongside senior cardiac clinical leaders.